Back to top
more

ResMed (RMD)

(Delayed Data from NYSE)

$184.22 USD

184.22
1,202,959

+3.87 (2.15%)

Updated Apr 23, 2024 03:59 PM ET

After-Market: $184.21 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (149 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for RMD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for ResMed Inc falls in the month of June.

All items in Millions except Per Share data.

6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Assets          
Cash & Equivalents 228 274 295 463 147
Receivables 705 576 614 475 528
Notes Receivable 0 0 0 0 0
Inventories 998 744 457 417 350
Other Current Assets 437 338 208 169 120
Total Current Assets 2,368 1,931 1,575 1,523 1,145
Net Property & Equipment 538 498 463 417 387
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 133 80 80 41 45
Intangibles 3,323 2,282 2,320 2,338 2,378
Deposits & Other Assets 262 172 161 149 151
Total Assets 6,752 5,096 4,728 4,587 4,108
Liabilities & Shareholders Equity 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Notes Payable 10 10 12 12 12
Accounts Payable 151 159 138 136 116
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 366 345 321 270 266
Income Taxes Payable 72 45 308 65 73
Other Current Liabilities 138 109 110 99 89
Total Current Liabilities 759 689 912 603 556
Mortgages 0 0 0 0 0
Deferred Taxes/Income 210 105 103 100 93
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,431 765 643 1,164 1,259
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 105 55 70 121 128
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 2,622 1,735 1,842 2,090 2,035
Shareholders Equity 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 1,772 1,682 1,622 1,571 1,511
Retained Earnings 4,253 3,614 3,080 2,833 2,436
Other Equity -273 -313 -193 -284 -253
Treasury Stock 1,623 1,623 1,623 1,623 1,623
Total Shareholder's Equity 4,130 3,361 2,886 2,497 2,072
Total Liabilities & Shareholder's Equity 6,752 5,096 4,728 4,587 4,108
Total Common Equity 4,130 3,361 2,886 2,497 2,072
Shares Outstanding 146.90 146.20 145.50 144.60 143.60
Book Value Per Share 28.11 22.99 19.83 17.27 14.43

Fiscal Year End for ResMed Inc falls in the month of June.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 210 209 228 228
Receivables NA 730 692 705 686
Notes Receivable NA 0 0 0 0
Inventories NA 933 958 998 1,011
Other Current Assets NA 505 445 437 412
Total Current Assets NA 2,378 2,305 2,368 2,338
Net Property & Equipment NA 552 534 538 529
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 156 138 133 96
Intangibles NA 3,390 3,375 3,323 3,353
Deposits & Other Assets NA 276 265 262 271
Total Assets NA 6,905 6,741 6,752 6,714
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 10 10 10 10
Accounts Payable NA 202 177 151 162
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 332 348 366 347
Income Taxes Payable NA 47 67 72 78
Other Current Liabilities NA 149 147 138 141
Total Current Liabilities NA 764 771 759 762
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 217 209 210 222
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 1,217 1,352 1,431 1,576
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 46 105 107
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 2,423 2,490 2,622 2,781
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 1,823 1,791 1,772 1,729
Retained Earnings NA 4,540 4,402 4,253 4,088
Other Equity NA -208 -320 -273 -262
Treasury Stock NA 1,673 1,623 1,623 1,623
Total Shareholder's Equity NA 4,482 4,250 4,130 3,933
Total Liabilities & Shareholder's Equity NA 6,905 6,741 6,752 6,714
Total Common Equity 0 4,482 4,250 4,130 3,933
Shares Outstanding 147.00 147.00 147.00 146.90 146.90
Book Value Per Share 0.00 30.49 28.91 28.11 26.77